サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404689

脳血栓除去装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product (Clot Retrievers, Aspiration/ Suction Devices), By End-use (Hospitals, Emergency Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 110 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳血栓除去装置の市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2024年～2030年
出版日: 2023年11月17日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳血栓除去装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の脳血栓除去装置市場規模は、2024年から2030年にかけてCAGR 6.87%で成長し、2030年には11億米ドルに達する見込みです。

市場の成長は、脳卒中の有病率の増加、不健康なライフスタイルの採用の増加、低侵襲手術の需要の増加、市場参入企業による様々な戦略的イニシアチブの採用など、様々な要因によって牽引されています。従来の開頭手術と比較して、これらのデバイスは創傷閉鎖を簡素化し、創傷治癒を早める利点を提供します。例えば、頭蓋内腔への容易なアクセス、最小限の侵襲、脳血栓除去装置に関連する高度な設計と機能による困難な処置の簡素化などです。

さらに、あらゆる年齢層でより審美的で自然な外観への関心が高まっていることや、低侵襲手術中の出血量が少ないことも市場成長の主な促進要因の一つです。このような処置は、侵襲的処置よりもさらに外傷を減らし、迅速な回復を促進するのに役立つと期待されています。このように、脳血栓除去装置は出血量が少なく、回復も早いため、低侵襲手術の需要が高まると予想されています。さらに、技術的に先進的な製品のイントロダクションと迅速な製品承認プロセスは、予測期間中の市場成長を促進すると予想される要因です。AISおよびその関連症状の治療用脳血栓除去装置の開発には、他にもさまざまな技術が用いられています。例えば、2023年6月、Penumbra社はlightning Bolt7動脈血栓除去システムを発表しました。この装置は、血栓と血流の違いを識別するのに役立ちます。

脳血栓除去装置市場レポートハイライト：

  • 製品別では、急性虚血性脳卒中の有病率の上昇と主要市場参入企業による製品発売の増加により、血栓回収装置が58.24%のシェアを占め、2023年の市場を独占しました。
  • 最終用途別では、医療施設の改善と病院での高度な機器の利用可能性により、病院分野が2023年に71.25%のシェアで市場を独占しました。
  • 欧州は、急性虚血性脳卒中患者の増加により、2023年に32.74%の最大売上シェアで市場をリードしました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 脳血栓除去装置の市場変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 脳血栓除去装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 脳血栓除去装置市場：製品の推定・動向分析

  • 定義と範囲
  • 製品市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 製品別の脳血栓除去装置市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第5章 脳血栓除去装置市場：最終用途の推定・動向分析

  • 定義と範囲
  • 最終用途市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 最終用途別の脳血栓除去装置市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第6章 脳血栓除去装置市場：地域の推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 地域市場シェアと主要企業、2023年
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東とアフリカ
  • 2018年から2030年の市場アプリケーション、予測および動向分析
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要ディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業市場シェア分析、2023年
    • Medtronic
    • Acandis GmbH
    • Phenox GmbH
    • Stryker
    • Penumbra, Inc.
    • Vesalio
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global neurothrombectomy devices market, by region 2018 - 2030 (USD Million)
  • Table 4 Global neurothrombectomy devices market, by product 2018 - 2030 (USD Million)
  • Table 5 Global neurothrombectomy devices market, by end-use 2018 - 2030 (USD Million)
  • Table 6 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 U.S. neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 U.S. neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Canada neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Europe neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Germany neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 France neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Italy neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Spain neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 Denmark neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 36 China neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 40 South Korea neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 42 Australia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait neurothrombectomy devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurothrombectomy devices market: Market snapshot
  • Fig. 9 Neurothrombectomy devices market: Market segmentation
  • Fig. 10 Neurothrombectomy devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurothrombectomy devices market driver impact
  • Fig. 14 Neurothrombectomy devices market restraint impact
  • Fig. 15 Neurothrombectomy devices market Porter's five forces analysis
  • Fig. 16 Neurothrombectomy devices market PESTEL analysis
  • Fig. 17 Neurothrombectomy devices market segment dashboard
  • Fig. 18 Neurothrombectomy devices market: Product movement Analysis
  • Fig. 19 Clot retrievers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Aspiration/ suction devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Vascular snares market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Neurothrombectomy devices market: End-use movement Analysis
  • Fig. 23 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Emergency clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global neurothrombectomy devices market: Regional movement analysis
  • Fig. 27 Global neurothrombectomy devices market: Regional outlook and key takeaways
  • Fig. 28 Global market share, by region
  • Fig. 29 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.10 billion by 2030, growing at 6.87% CAGR from 2024 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2023, with a share of 58.24% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players
  • Based on end-use, hospital segment dominated the market in 2023 with a share of 71.25% due to improving health care facilities and the availability of advanced equipment in the hospitals
  • Europe led the market with the maximum revenue share of 32.74% in 2023, owing to the increasing number of patients suffering from acute ischemic stroke in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of acute ischemic strokes
      • 3.4.1.2. Introduction of technologically advanced products
      • 3.4.1.3. Rising Adoption of unhealthy lifestyle
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Stringent and complex regulatory framework
      • 3.4.2.2. Risks associated with the neurothrombectomy devices
  • 3.5. Neurothrombectomy Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. The threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Clot Retrievers
    • 4.1.2. Aspiration/Suction Devices
    • 4.1.3. Vascular Snares
  • 4.2. Type Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Neurothrombectomy Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Clot Retrievers
      • 4.5.1.1. Clot Retrievers market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Aspiration/Suction Devices
      • 4.5.2.1. Aspiration/Suction Devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3 Vascular Snares
      • 4.5.3.1 Vascular Snares market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Hospital
    • 5.1.2. Emergency Clinics
    • 5.1.3. Ambulatory Surgical Centers
  • 5.2. End-use Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurothrombectomy Devices Market by End-use Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Hospital
      • 5.5.1.1. Hospital market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Emergency Clinics
      • 5.5.2.1. Emergency Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Ambulatory Surgical Centers
      • 5.5.3.1. Ambulatory Surgical Centers market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Acandis GmbH
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Phenox GmbH
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Stryker
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Penumbra, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Vesalio
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives